- All sections
- C - Chemistry; metallurgy
- C07D - Heterocyclic compounds
- C07D 471/04 - Ortho-condensed systems
Patent holdings for IPC class C07D 471/04
Total number of patents in this class: 22986
10-year publication summary
1518
|
1657
|
1573
|
1752
|
1834
|
2017
|
1918
|
2011
|
1952
|
595
|
2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
Bristol-myers Squibb Company | 5080 |
519 |
Merck Patent GmbH | 5909 |
356 |
Novartis AG | 11238 |
343 |
F. Hoffmann-La Roche AG | 7958 |
337 |
Takeda Pharmaceutical Company Limited | 2961 |
317 |
Janssen Pharmaceutica N.V. | 3839 |
304 |
Merck Sharp & Dohme LLC | 3689 |
303 |
Boehringer Ingelheim International GmbH | 4629 |
242 |
Hoffmann-La Roche Inc. | 3060 |
225 |
Incyte Corporation | 918 |
224 |
Amgen Inc. | 3779 |
219 |
Gilead Sciences, Inc. | 1879 |
217 |
Genentech, Inc. | 3742 |
205 |
Pfizer Inc. | 3322 |
197 |
Dana-Farber Cancer Institute, Inc. | 2455 |
183 |
AstraZeneca AB | 3042 |
173 |
Bayer Pharma AG | 1096 |
170 |
Abbvie Inc. | 1808 |
167 |
Vertex Pharmaceuticals Incorporated | 1581 |
154 |
Bayer AG | 3045 |
145 |
Other owners | 17986 |